Stock 6610 TWI BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company TWi Biotechnology, Inc.

Equities

6610

TW0006610009

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
12.35 TWD +0.82% Intraday chart for TWi Biotechnology, Inc. -3.89% -11.79%
04-09 TWi Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 TWi Biotechnology, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

TWi Biotechnology, Inc. is a Taiwan-based clinical stage biopharmaceutical company specializing in the development of new drugs for unmet medical needs, especially in diseases associated with innate immunity. The company is building its product pipeline through in-licensing and internal research. Its product development pipeline includes two drug candidates for treating type II diabetes, arthritis, and immunodermatology diseases and others. It’s still in the research and development stage, its operating income is the contract revenue from the signing of the contract with the Castal Creek Pharmaceuticals (CCP) about its drug AC-203 for the treatment of epidermolysis bullosa (EB). It mainly aims at America market.

Number of employees: 21

Managers

Managers TitleAgeSince
Chu Chun Weng CEO
 Chief Executive Officer - -
Lien I Ho DFI
 Director of Finance/CFO - -
Kuang Wei Lu CTO
 Chief Tech/Sci/R&D Officer - -
Emily Lin PRN
 Corporate Officer/Principal - -
Pei Lan Chu AUD
 Comptroller/Controller/Auditor - -

Members of the board

Members of the board TitleAgeSince
Li Yan Chang BRD
 Director/Board Member - 15/08/21
Jonas Wang BRD
 Director/Board Member - 04/06/19
Yi Chun Wu CHM
 Chairman - -
Yueh Yueh BRD
 Director/Board Member - -
Sen Hsiung Chang BRD
 Director/Board Member - 15/08/21
Chia Ching Chen BRD
 Director/Board Member - -
Chu Chun Weng CEO
 Chief Executive Officer - -
Pei Chih Chen BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 87,649,395 67,794,395 ( 77.35 %) 0 77.35 %

Company contact information

TWi Biotechnology, Inc.

8th Floor No. 41, Lane 221, Kang Chien Road

114 94, Taipei

+

http://www.twibiotech.com
address TWi Biotechnology, Inc.(6610)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
TWI BIOTECHNOLOGY, INC. Stock TWi Biotechnology, Inc.
-11.79% 33.36M
MODERNA, INC. Stock Moderna, Inc.
+54.05% 63.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-2.02% 41.83B
LONZA GROUP AG Stock Lonza Group AG
+40.01% 40.47B
CELLTRION, INC. Stock Celltrion, Inc.
-10.22% 27.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.42% 26.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.60% 18.69B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+2.89% 12.73B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+22.40% 12.11B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.49% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. 6610 Stock
  4. Company TWi Biotechnology, Inc.